CBS 2019
CBSMD教育中心
中 文

推荐文献

Abstract

Recommended Article

The year in cardiovascular medicine 2020: interventional cardiology Long-Term Effect of Ultrathin-Strut Versus Thin-Strut Drug-Eluting Stents in Patients With Small Vessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: A Subgroup Analysis of the BIOSCIENCE Randomized Trial Appropriate Use Criteria and Health Status Outcomes Following Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From the OPEN-CTO Registry Position paper of the EACVI and EANM on artificial intelligence applications in multimodality cardiovascular imaging using SPECT/CT, PET/CT, and cardiac CT Coronary Angiography after Cardiac Arrest — The Right Timing or the Right Patients? Management of Percutaneous Coronary Intervention Complications: Algorithms From the 2018 and 2019 Seattle Percutaneous Coronary Intervention Complications Conference Association of CYP2C19 Loss-of-Function Alleles with Major Adverse Cardiovascular Events of Clopidogrel in Stable Coronary Artery Disease Patients Undergoing Percutaneous Coronary Intervention: Meta-analysis Plaque progression assessed by a novel semi-automated quantitative plaque software on coronary computed tomography angiography between diabetes and non-diabetes patients: A propensity-score matching study

GuidelineJanuary 2019

JOURNAL:J Am Coll Cardiol. Article Link

2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society

CT January, LS Wann, H Calkins et al. Keywords: Anticoagulation Management; Arrhythmias and Clinical EP; Heart Failure and Cardiomyopathies; Invasive Cardiovascular Angiography and Intervention; Prevention; Valvular Heart Disease; Anticoagulation Management and Atrial Fibrillation; Implantable Devices; SCD/Ventricular Arrhythmias; Atrial Fibrillation/Supraventricular Arrhythmias; Novel Agents; Acute Heart Failure; Interventions and Structural Heart Disease

FULL TEXT PDF